Planck Integrates Latest GPT Tech to Revolutionize Business Risk Analysis
Commercial underwriters face significant challenges when it comes to navigating business risk research. Commercial risk is more complex. It has become increasingly difficult and time-consuming for underwriters to gather and understand the information they need to make informed decisions. This is why the application of large language models (LLMs) like GPT provides such significant advancement to the practice of underwriting: it scales the underwriter’s ability to keep pace with and comprehend massive amounts of information.
Planck has spent years working with LLMs similar to GPT, and since 2022 specifically with GPT-type models. And while GPT is impressive on its own for less specific use cases, certain tasks like fact-checking, multimedia research, risk assessment, and gathering evidence require deeper capabilities. Planck’s proprietary AI provides GPT with context and focus for the unique applications and requirements of commercial insurance underwriting.
“Our mission at Planck has always been to empower commercial insurers with the tools and insights they need to navigate business risk effectively,” says
Planck allows underwriters to customize risk queries for unique perspectives and needs, and uncover even deeper insights through advanced language processing. And unlike black-box solutions, Planck provides evidence-based transparency, giving underwriters a clear understanding of the ‘why’ behind the insights to ensure full accountability.
“With Planck’s platform and the latest GPT, we are revolutionizing the underwriting process in commercial insurance,” says
While GPT technology has gained widespread attention recently for its ability to enhance various industries, Planck has been operating at the forefront of AI application in commercial insurance for years. The integration of GPT technology in its platform is the result of extensive research and development by Planck's data engineers, who continue to develop the potential of this and other advanced machine learning algorithms for the commercial insurance industry.
About Planck
Planck is a leading provider of AI-enhanced business risk data for commercial insurers. Planck enables insurers to drive service and underwriting excellence by connecting the most up-to-date insights, with limited submission input. Global carriers, MGAs, and insurtechs leverage Planck’s holistic solution for customer acquisition and growth strategies, submission validation, underwriting new business, renewing existing policies, premium auditing and more. The platform makes managing risk much faster and more predictable, resulting in increased written premium while reducing loss and expense ratios.
Planck was founded by a team of relentless entrepreneurs with extensive backgrounds in insurance and technology. The company has raised
For more information, visit www.planckdata.com.
Media Contact
[email protected]
Source: Planck



Lexasure Financial Group Launches LexasureCloud 1.0 Digital B2B2C InsurTech Platform at InsureTech Connect Asia
One80 Intermediaries Appoints Blake Swearengin as National Casualty Practice Leader
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
- School, BOCES healthcare costs up 22%, here’s why
- Healthcare cuts threaten Sullivan's reelection chances in Alaska
- Health insurance marketplace feels growing tremors from GOP cuts
More Health/Employee Benefits NewsLife Insurance News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
More Life Insurance News